Our immunohistochemistry results showed that ATF4 is strongly expressed in mutant p53 type ovarian cancer human samples (p = 0.00749) and a high ATF4 expression level is correlated with a poor prognosis in patients with ovarian cancers (p = 0.0045). The gene discussed is ATF4; the disease is ovarian carcinoma.